A worldwide pioneer in biotechnology
Amgen is a multinational biopharmaceutical company and pioneer of the biotechnology industry, founded in 1980 in Thousand Oaks, California. The company uses human genetic data and cutting-edge biology to discover and manufacture innovative medicines targeting serious illnesses including cancer, cardiovascular disease, osteoporosis, and inflammatory conditions. Amgen's portfolio spans both novel biologics and biosimilars, reaching millions of patients across more than 100 countries. With over 40 years of experience in recombinant DNA technology, Amgen remains one of the world's largest independent biotechnology companies.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account